Altres línies
Publicacions (614)
Naudi, A; Cabre, R; Dominguez-Gonzalez, M; Ayala, V; Jove, M; Mota-Martorell, N; Pinol-Ripoll, G; Pilar Gil-Villar, Maria; Rue, M; Portero-Otin, M; Ferrer, I; Pamplona, R
Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 1862 485-495. .
Marsal JR; Ferreira-González I; Bertran S; Ribera A; Permanyer-Miralda G; García-Dorado D; Gómez G
The Use of a Binary Composite Endpoint and Sample Size Requirement: Influence of Endpoints Overlap
AMERICAN JOURNAL OF EPIDEMIOLOGY 185 832-841. .
Jose Cruz-Jentoft, Alfonso; Gonzalez, Bernardo; de la Rubia, Javier; Hernandez Rivas, Jose Angel; Alfonso Soler, Juan; Fernandez Lago, Carlos; Arnao, Mario; Gironella, Mercedes; Perez Persona, Ernesto; Teresa Zudaire, Maria; Olivier, Carmen; Altes, Alberto; Garcia Guinon, Antonio; Nomdedeu, Benet; Arnan, Montserrat; Ramirez Payer, Angel; Sanchez-Godoy, Pedro; Pajuelo, Nuria; Vilanova, David; Fernanez Monjil, Diego; Bonanad, Santiago
Further psychometric validation of the GAH scale: Responsiveness and effect size
Journal of Geriatric Oncology 8 211-215. .
Domingo, P; Sancho, F
Neisseria meningitidis and purpura fulminans in a woman with chronic liver disease
LANCET INFECTIOUS DISEASES 17 459-459. .
Senent, L.; Lorenzo, I.; Vicente, A.; Alonso, E.; Sanzo, C.; Ramos, F.; Arenillas, L.; Orero, M.; Navarro, B.; Marco, V.; Diez Campelo, M.; Jerez, A.; Montoro, J.; Arrizabalaga, B.; Bonanad, S.; Lluch, R.; Paz, R. D.; Font, P.; Gomis, F.; Sanz, G.
PROGNOSTIC IMPLICATION OF THE PERCENTAGE OF ERYTHROID CELLS IN BONE MARROWAT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
LEUKEMIA RESEARCH 55 151-152. .
Cabezon, M.; Bargay, J.; Xicoy, B.; Garcia, O.; Tormo, M.; Palomo, L.; Marce, S.; Valcarcel, D.; Pedro, C.; Jimenez, M. J.; Borras, J.; Guardia, R.; Brunet, S.; Marti, J. M.; Garcia, A.; Zamora, L.
TP53 MUTATIONS IN HIGH RISK MYELODYSPLASTIC SYNDROMES PATIENTS TREATED WITH AZACITIDINE ACCORDING TO CETLAM GROUP PROTOCOL
LEUKEMIA RESEARCH 55 155-155. .
Redondo Guijo, A. M.; Sanchez-Barba, M.; Sanz Santillana, G.; Bernal, T.; Arnan Sangerman, M.; Ramos Ortega, F.; Pedro Olive, C.; Amigo Lozano, M. L.; Marco Betes, V.; Valcarcel, D.; Ardanaz, M.; Brunet, S.; Bargay Lleonart, J.; Tormo, M.; Xicoy, B.; Nomdedeu, M.; Lopez Cadenas, F.; Caballero Berrocal, J. C.; Canizo, M. C. D.; Diez-Campelo, M.
WHAT IS THE OUTCOME OF PATIENTS IN THE INTERMEDIATE IPSS-R SCORE GROUP? SPANISH APPROACH FOR BETTER STRATIFICATION WITH CLASSICAL TOOLS
LEUKEMIA RESEARCH 55 150-151. .
Colas-Meda, P; Viñas I; Oliveira, M; Anguera, M; Serrano, JCE; Abadias, M
Exposure to minimally processed pear and melon during shelf life could modify the pathogenic potential of Listeria monocytogenes
FOOD MICROBIOLOGY 62 275-281. .
Diaz-Gomez, J; Twyman, RM; Zhu, CF; Farre, G; Serrano, JCE; Portero-Otin, M; Muñoz, P.; Sandmann, G; Capell, T; Christou, P
Biofortification of crops with nutrients: factors affecting utilization and storage
CURRENT OPINION IN BIOTECHNOLOGY 44 115-123. .
Pifarre, M; Carrera, A; Vilaplana, J; Cuadrado, J; Solsona, S; Abella, F; Solsona, F; Alves, R
TControl: A mobile app to follow up tobacco-quitting patients
Computer Methods and Programs in Biomedicine 142 81-89. .
Huerva, V; Traveset, AE; Vilardell, F
Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia
Ocular Immunology And Inflammation 25 284-286. .
Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. .
